News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - IPO, Updates (World)
Zai Lab Completes $150 Million IPO; Stock Jumps 50% At Opening; Company Worth $1.4 Billion 9/20/2017
Zai Lab Plans $90 Million IPO At $800 Million Valuation 9/14/2017
Week In Review: BGI Genomics Completes $81 Million Chi-Next IPO 7/17/2017
Argenx Announces Closing Of NASDAQ IPO 5/24/2017
Booming Wuxi Biologics Gears Up For $513 Million IPO 5/24/2017
Argenx Raises Approximately $100 Million Gross Proceeds With NASDAQ IPO 5/18/2017
Argenx Announces Size Of Initial Public Offering In The United States Increased To 5 Million ADSs 5/16/2017
Argenx Announces Launch Of Proposed Initial Public Offering In The United States 5/8/2017
UroGen Announces Pricing Of Initial Public Offering 5/4/2017
Therapix Announces Closing Of U.S. Initial Public Offering Of American Depositary Shares; 2,000,000 American Depository Shares Priced At $6.00 Per ADS 3/28/2017
Wenzel Spine Acquires OsteoMed's Interspinous & Facet Fixation Product Platforms for Undisclosed Sum 2/22/2017
Siemens (SI) Mulls Over U.S. IPO of Its Healthcare Biz 2/14/2017
Siemens (SI) Eyes IPO of Its Healthcare Biz 11/10/2016
Ascendis Eyes $112 Million IPO to Fund the Development of Growth Hormone Drug 10/19/2016
ObsEva Announces Plans To Conduct Initial Public Offering In The United States 10/17/2016
ConvaTec Looks to Raise $1.8 Billion in London IPO 10/3/2016
Myovant Files for $172.5 Million IPO 10/3/2016
Alzheimer's Biotech AC Immune SA Eyes $700 Million IPO Valuation 9/14/2016
Gene Editing Phenom CRISPR (CRSP) Files for $90 Million IPO 9/12/2016
Tech Fund With Focus on Healthcare, Cambridge Innotavion Capital, Scores $98.5 Million 8/23/2016
Oventus IPO Opens 6/16/2016
Merus (MRUS) Announces Closing Of Initial Public Offering 5/25/2016
Poxel Plans To Conduct Registered Initial Public Offering In The United States 5/4/2016
Samsung Biologics Eyes $2.6 Billion IPO in Korea This Year 4/28/2016
Royal Philips Electronics N.V. (PHG) Falls as Lighting IPO Looks Increasingly Likely 4/25/2016
Royal Philips Electronics N.V. (PHG) Said to Name Banks for Possible Lighting Unit IPO 4/5/2016
Hutchison China MediTech (Chi-Med) Announces Closing Of U.S. Public Offering Of Adss Raising Approximately US$101 Million On The Nasdaq Stock Market 3/22/2016
BeiGene Announces Closing Of Its Initial Public Offering 2/9/2016
BeiGene Announces Pricing Of Its Initial Public Offering 2/3/2016
Mapi Pharma Tries Again to List on Nasdaq, Sets Terms for $50 Million IPO 1/26/2016
REVA Medical Considers IPOing Next Year 11/23/2015
Strongbridge Biopharma Announces Closing Of Initial U.S. Public Offering 10/22/2015
Advanced Inhalation Therapies Reveals Finances Ahead of $36 Million IPO 10/20/2015
Bayer (BAY)'s Covestro May Postpone IPO After VW Scandal 10/2/2015
Strongbridge Biopharma Preps for $76 Million U.S. IPO 9/22/2015
Bayer (BAY)'s Spinoff Covestro to Go Public in Fourth Quarter 9/4/2015
Samsung Bioepis Taps Banks for Planned Nasdaq IPO 8/20/2015
ERYtech Pharma Announces Plans To Conduct Registered Initial Public Offering In The United States 7/28/2015
Cortendo Announces Plans To Conduct Registered Initial Public Offering Of Its Common Shares 7/20/2015
Chiasma Prices Initial Public Offering Of Common Stock 7/16/2015
Celyad Preps for $99 Million IPO 6/16/2015
Cosmo Pharm Eyes $107 Million+ in Dermatology Unit IPO 6/15/2015
Ousted Sanofi (SAN.PA) Exec's New Company Aims For $160 Million London IPO 5/27/2015
BiondVax Pharmaceuticals Announces Closing of U.S. IPO 5/15/2015
SanBio, Inc. Announces Pricing Of Initial Public Offering On Tokyo Stock Exchange 4/8/2015
Summit Therapeutics Announces Closing Of Its U.S. Initial Public Offering 3/11/2015
Summit Therapeutics Announces Pricing Of U.S. Initial Public Offering And Nasdaq Global Market Listing 3/5/2015
Malin, Formed by Ex-Elan (ELN) Execs, Eye Up to $365 Million in Biotech IPO 3/4/2015
Nexvet Biopharma Announces Closing Of Initial Public Offering 2/11/2015
BBI Life Sciences Stages $37 Million IPO in Hong Kong 2/5/2015
GlaxoSmithKline (GSK) Brings Three Banks on Board to Advise on Potential IPO 2/5/2015
Cantargia Performs IPO Ahead Of Planned Listing On Nasdaq First North In Stockholm 1/16/2015
Evolving GlaxoSmithKline (GSK) Mulls Over More Unit IPOs 1/16/2015
Selvita Has Raised PLN 27.3 MM On Its Way To The Main Market Of The Warsaw Stock Exchange 12/16/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data 12/3/2014
Job Cuts Loom Over GlaxoSmithKline (GSK) As It Aims To Cut Costs; Eyes IPO Of HIV Unit 10/23/2014
Largest Biotech IPO Yet Could Be Derailed By Forward Pharma (FWP), Biogen Idec (BIIB) Patent Fight 10/15/2014
VBL Therapeutics (VBLX) Announces Closing Of Initial Public Offering 10/7/2014
Forward Pharma (FWP) Announces Proposed IPO Of ADSs 10/2/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Closing Of Initial Public Offering 9/24/2014
Swiss Biotech Firm Molecular Partners AG Plans $134 Million IPO 9/23/2014
Affimed Therapeutics AG (AFMD) Announces Closing Of Initial Public Offering 9/18/2014
Auris Medical AG (EARS) Announces Exercise Of IPO Over-Allotment Option 8/20/2014
Israeli Biotech Foamix Files For A $75 Million IPO 8/14/2014
Multiple Sclerosis Biotech Forward Pharma Files For $200 Million IPO 8/12/2014
Innocoll AG Announces Pricing Of Initial Public Offering 7/25/2014
Orthocell Raises $8 Million In Oversubscribed IPO 7/22/2014
Luye Pharma Group Ltd. Completes Successful IPO In Hong Kong 7/14/2014
Luye Pharma Group Ltd. Prices Hong Kong IPO At Top Of Range 7/7/2014
GW Pharmaceuticals Announces The Closing Of U.S. Public Offering Of American Depositary Shares (Adss) Totaling Approximately $169.8 Million On The NASDAQ Global Market And Full Exercise Of Underwriters' Option To Purchase Additional Adss 6/26/2014
GlaxoSmithKline (GSK) Spin-Off Convergence Pharmaceuticals Gears Up For Possible Listing 6/17/2014
Dutch Biotech arGEN-X Plans To Go Public In Brussels 6/10/2014
Orthocell IPO Opens 6/5/2014
MediWound (MDWD) Prices IPO At $14 Share 3/20/2014
Galmed Pharmaceuticals Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 3/18/2014
Circassia Limited (CIR.L) Raises $332 Million In IPO Debut, Largest Biotech IPO Since 1995 3/14/2014
Galmed Pharmaceuticals Debuts Upsized IPO, Raises $38 Million 3/13/2014
NeuroVive Pharmaceutical AB: Neurovive Starts Collaboration To Evaluate IPO Of Subsidiary In Taiwan 3/10/2014
Durham's SCYNEXIS, Inc. Files For $55 Million IPO 3/3/2014
Beijing Genomics Institute (BGI) Rumored To Stage $400 Million IPO In Late 2014 2/24/2014
Luye Pharma Group Ltd. To Conduct $750 Million Hong Kong IPO 2/10/2014
Circassia Limited Seeks $285 Million In One Of Europe's Biggest Biotech IPOs 2/6/2014
uniQure Announces Pricing Of Initial Public Offering 2/5/2014
Seattle Biotech Acucela Inc. Sets Terms Of $162 Million Japanese IPO 2/4/2014
Zhejiang Wolwo Bio-Pharma Gains 94% Post-IPO 1/27/2014
Gene Therapy Biopharma uniQure Sets Terms For $64 Million IPO 1/27/2014
TaiGen Biotechnology Raises $36 Million In Taiwan IPO 1/20/2014
Jiangsu ASK Pharma Postpones ChiNext IPO 1/13/2014
Seattle Biotech Acucela Inc. Seeks $125 Million IPO in Japan to Develop Eye Drugs 12/18/2013
Consun Pharma Schedules Hong Kong IPO 12/13/2013
Innate Immunotherapeutics Launches IPO To Raise Up To A$12 Million 11/27/2013
Evogene Ltd. (EVGN) Hauls In $74 Million In IPO 11/21/2013
Enzymotec Announces Pricing of Its Initial Public Offering 9/27/2013
Prosensa Holding N.V. Announces Closing of Initial Public Offering 7/8/2013
ProSensa B.V. Raises $78 Million in IPO 6/28/2013
CSRC Terminates IPO Applications of 15 China Life Science Companies 6/6/2013
Kamada Ltd. (KMDA.TA) Announces Pricing of Initial Public Offering 6/5/2013
Cancer Drug Spinoff of Australian Company, Audeo Oncology Inc. Preps $49 Million IPO 12/10/2012
BioIndustry Association Release: Latest French Biotech IPO Demonstrates the Potential of Citizens' Innovation Funds 10/25/2012
Fosun Pharma's Hong Kong IPO Set to Raise $600 Million 10/5/2012
China National Biotech Group Approved for $1.6 Billion Hong Kong IPO 9/6/2012
The Week in Review: Tigermed and Shuangcheng Pharma Complete IPOs 8/21/2012
Tigermed Completes $80 Million IPO on the ChiNext Exchange 8/20/2012
Hainan Shuangcheng Pharma Stages $94 Million IPO in Shenzhen 8/15/2012
Cathay Industrial Biotech Withdraws $90 Million IPO 6/13/2012
China National Biotech Group to Raise $1.6 Billion in Hong Kong IPO 5/18/2012
Fosun Pharma Given OK for Hong Kong IPO 4/12/2012
Beijing Leadman Biochemistry Completes ChiNext IPO 2/16/2012
Chinese Drugmaker Guizhentang Pharmaceuticals' IPO Protested Over Bear Bile 2/13/2012
Xizang Haisco Pharma Completes $127 Million IPO 1/17/2012
China National Biotech Group's Hong Kong IPO to Raise Up to $2 Billion 11/9/2011
Shijiazhuang Yiling Pharmaceutical Climbs in Post-IPO Trading 7/28/2011
U.S. HIV Drug Firm Koronis Pharmaceuticals, Inc. Looks to London Listing 3/14/2011
CRO ShangPharma Plans $90 Million IPO on the NYSE 10/5/2010
Yunnan Walvax Biotech to IPO on ChiNext Exchange 9/14/2010
China Pharma IPOs Raise $5.4 Billion in 12 Months 7/26/2010